跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,896 条关于
“IL-23/IL-17A”
全部
6,896
临床试验
2,636
药物
1,285
机构
143
资讯
2,832
10个月前
UNION Therapeutics Publishes Biomarker Data Showing Orismilast's Multi-Pathway Anti-Inflammatory Effects in Psoriasis
去年
Secukinumab Shows Superior Efficacy Over Ustekinumab in Clearing Skin for Generalized Pustular Psoriasis
去年
Kronos Bio Advances Autoimmune Pipeline with KB-7898 for Sjögren's Disease
去年
MC2 Therapeutics Names Trine Ahlgreen as CEO to Drive Global Expansion of Psoriasis Treatment Wynzora
去年
IL-17 and IL-23 Inhibitors Show Promising Safety and Efficacy Profiles in Elderly Psoriasis Patients
去年
Bimzelx Approved by FDA as First IL-17A and IL-17F Inhibitor for Hidradenitis Suppurativa
去年
Endo and Paladin Pharma Partner to Launch Wynzora Cream in Canada for Plaque Psoriasis
去年
C4X Discovery Receives €8 Million Milestone from Sanofi for Oral IL-17A Inhibitor Progress
去年
FDA Approves UCB's Bimzelx (bimekizumab-bkzx) for Hidradenitis Suppurativa
去年
Livzon's Dual-Target IL-17A/F Antibody LZM012 Outperforms Secukinumab in Phase III Psoriasis Trial
第 1 页,共 284 页
上一页
下一页